Serum levels and differential expression of intercellular adhesion molecule-1 in childhood leukemia and malignant lymphoma: Prognostic importance and relationship with survival

Pediatric Hematology and Oncology

Volumn 16, Issue 2, 1999, Pages 149-158

  Tacyildiz, Nurdan ^a,c   Yavuz, Gulsan ^a   Gozdasoglu, Sevgi ^a   Unal, Emel ^a   Ertem, Ulya ^b   Duru, Feride ^b   Ikinciogullari, Aydan ^a   Babacan, Emel ^a   Ensari, Arzu ^a   Okcuoglu Cavdar, Ayhan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^c Department of Pathology ^*  (Turkey)

Author keywords

ICAM 1; Leukemia; Lymphoma

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBODY TITER; ARTICLE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; MALE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0033004070     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277470     Document Type: Article

References (20)

1. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 is a ligand for lymphocyte function associated antigen 1 (LFA-1). Cell. 1987;51:813-819.
2. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev. 1990;114:181-217.
3. Pizzolo G, Vinante F, Nadali G, et al. ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease. Br J Haematol. 1993;84:161-162.
4. Maio M, Pinto A, Carbone A, et al. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders. Blood. 1990;76:783-790.
5. 2-integrins), CD54(ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia. Leuk Lymphoma. 1994;13:297-306.
6. Archimboud E, Thomas X, Campos L, et al. Expression of surface adhesion molecular CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis. Leukemia. 1992;6:265-271.
7. Rothlein R, Mainolfi EA, Czajkowski M, et al. A form of circulating ICAM-1 in human serum. J Immunol. 1991;147:3788-3793.
8. Harning R, Mainolfi E, Bystryn JC, et al. Serum levels of circulating intercellular adhesion molecule-1 in human malignant lymphoma. Cancer Res. 1991;51:5003-5005.
9. Gruss HJ, Dolken G, Brach M, et al. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. Leukemia. 1993;7:1245-1249.
10. Christiansen L, Gidlof C, Walgren AC, et al. Serum levels of soluble inter cellular adhesion molecule-1 are increased in B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood. 1994;84:3010-3016.
11. Pui CH, Luo X, Evans W, et al. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood. 1993;82:895-898.
12. Hatzistilianou M, Athanassiadou F, Agguridaki C, et al. Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukemia. Eur J Pediatr. 1997;156:537-540.
13. Mielcarek M, Sperling C, Schrappe M, et al. Expression of intercellular adhession molecule-1 (ICAM-1) in chilhood acute lymphoblastic leukemia: correlation with clinical features and outcome. Br J Haematol. 1997;96:301-307.
14. Bennet JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. Br J Haematol. 1976;33:451-458.
15. Lukes RJ, Craver LF, Hall TC, et al. Report of the Nomenclature Committee. Cancer Res. 1966;26:1311.
16. Berard C, O'Conor GT, Thomas LB, et al. Histopathological definition of Burkitt's tumor. Bull World Health Organ. 1969;40:601-607.
17. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgin's disease staging. Cancer Res. 1971;31:1860-1861.
18. Mason DY, Woolson RE. Double immuno-enzymatic labeling. In: Bullock G, Petrus P, eds. Techniques in Immunocytochemistry. Vol. 1. London: Academic; 1982:135-152.
19. Romagnani S, Rossi Ferrini PL, Ricci M. The immune derangement in Hodgkin's disease. Semin Hematol. 1985;22:41-55.
20. Horst E, Radaszkiewicz T, Hooftman-dan Otter AH, et al. Expression of leukocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia. 1991;5:848-853.